Core Viewpoint - The company, Guangzhou Kingmed Diagnostics Group Co., Ltd., anticipates a net loss for the fiscal year 2025, primarily due to extended collection periods for accounts receivable leading to significant credit impairment losses [1]. Financial Performance - The company expects the net profit attributable to shareholders for 2025 to be negative, indicating an operational loss for the year [1]. - The final financial data will be disclosed in the official 2025 annual report, which will provide the confirmed figures [1]. Compliance and Disclosure - The company commits to adhering to the Shanghai Stock Exchange listing rules and will expedite its financial accounting processes to release the 2025 annual performance forecast promptly [1]. - Designated media for information disclosure includes China Securities Journal, Shanghai Securities Journal, Securities Times, Securities Daily, and the Shanghai Stock Exchange website [1].
广州金域医学检验集团股份有限公司 关于2025年年度业绩预告的提示性 公告